InsidersTradesSigma
Track the Nexalis Therapeutics Ltd stock price and the full directors' dealings record of the company, a listed issuer based in Australia. Shares are listed on the AU market, under the authority of ASX. Operating in the Health Care sector, Nexalis Therapeutics Ltd has published 4 reports. Market capitalisation: €2.8m. The latest transaction was disclosed on 30 July 2026 (Change in Substantial Holding). Among the most active insiders: NFPFRN (if applicable). The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
4 of 4 declarations
Nexalis Therapeutics Ltd 是一家专注于医疗保健和制药领域创新疗法开发的公司。该公司在 XASX 市场上市。